Rechercher | Applechat

Rahul Rangwa Ajouter une nouvelle offre d'emploi Autre
2026-06-16 09:22:48 -

Metabolic Syndrome Market Advances with Growing Focus on Early Diagnosis and Preventive Healthcare
" According to the latest report published by Data Bridge Market Research, the Metabolic Syndrome Market CAGR Value The global metabolic syndrome market size was valued at USD 82.79 billion in 2025and is expected to reach USD 147.65 billion by 2033, at a CAGR of 7.50% during the forecast period The Metabolic Syndrome Marketdocument identifies and analyses...

0 Commentaires 0 Parts 41 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Pratiksha Dhote Ajouter une nouvelle offre d'emploi Health
2026-04-16 09:29:38 -

Bariatric surgery: drastic, but it cures metabolic syndrome in 80% of patients
Let's be real: surgery seems extreme. But for people with severe obesity (BMI >40) or BMI >35 with complications, bariatric surgery (gastric bypass, sleeve) is the most effective treatment. The metabolic syndrome market forecast shows that surgery is the fastest‑growing treatment segment, with a CAGR above 9%. Why? Because it doesn't just reduce weight — it changes gut...

0 Commentaires 0 Parts 540 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Pratiksha Dhote Ajouter une nouvelle offre d'emploi Health
2026-04-14 11:24:18 -

Bariatric surgery: drastic, but it cures metabolic syndrome in 80% of patients
Let's be real: surgery seems extreme. But for people with severe obesity (BMI >40) or BMI >35 with complications, bariatric surgery (gastric bypass, sleeve) is the most effective treatment. The metabolic syndrome market forecast shows that surgery is the fastest‑growing treatment segment, with a CAGR above 9%. Why? Because it doesn't just reduce weight — it changes gut...

0 Commentaires 0 Parts 509 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Pratiksha Dhote Ajouter une nouvelle offre d'emploi Health
2025-12-09 12:55:39 -

PPAR Agonist Product Types: Comparison of Brand Offerings and Strategy for Market Share Capture
PPAR Agonists (Product types) remain foundational pharmacological agents in the management of specific components of Metabolic Syndrome, particularly in addressing Dyslipidemia Management (Use cases) and insulin resistance. These agents target nuclear receptors involved in lipid and glucose metabolism, offering a precise mechanism of action for cardiovascular risk reduction....

0 Commentaires 0 Parts 2KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!